AlphaCore Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$682K Sell
2,435
-3,532
-59% -$928K 0.01% 568
2026
Q1
$1.59M Buy
5,967
+686
+13% +$186K 0.04% 295
2025
Q4
$1.32M Buy
5,281
+1,915
+57% +$509K 0.03% 346
2025
Q3
$966K Buy
3,366
+419
+14% +$112K 0.03% 307
2025
Q2
$774K Buy
+2,947
New +$718K 0.03% 297

Other funds holding LH

AlphaCore Capital's LH Position: Q2 2026 in Review

AlphaCore Capital reduced its Labcorp (LH) stake by 59% in Q2 2026, selling an estimated $928K and leaving 2,435 shares worth $682K. The position accounts for 0.01% of the portfolio, ranked #568.

AlphaCore Capital first reported a position in LH in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.59M in Q1 2026. 1,059 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • AlphaCore Capital held 2,435 shares of Labcorp worth $682K as of Q2 2026.
  • AlphaCore Capital sold 3,532 Labcorp shares in Q2 2026, an estimated $928K.
  • Labcorp made up 0.01% of AlphaCore Capital's portfolio in Q2 2026, its #568 holding.
  • AlphaCore Capital first reported a position in Labcorp in Q2 2025 and has held it in 5 quarters since.
  • AlphaCore Capital's Labcorp position peaked at $1.59M in Q1 2026.
  • 1,059 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.